Abstract
Pseudohypoparathyroidism (PHP) and pseudopseudohypoparathyroidism (PPHP) are caused by mutations and/or epigenetic changes at the complex GNAS locus on chromosome 20q13.3 that undergoes parent-specific methylation changes at several sites. GNAS encodes the alpha-subunit of the stimulatory G protein (Gsα) and several splice variants thereof. Heterozygous inactivating mutations involving the maternal GNAS exons 1–13 cause PHP type Ia (PHP1A). Because of much reduced paternal Gsα expression in certain tissues, such as the proximal renal tubules, thyroid, and pituitary, there is little or no Gsα protein in the presence of maternal GNAS mutations, thus leading to PTH-resistant hypocalcemia and hyperphosphatemia. When located on the paternal allele, the same or similar GNAS mutations are the cause of PPHP. Besides biochemical abnormalities, patients affected by PHP1A show developmental abnormalities, referred to as Albrights hereditary osteodystrophy (AHO). Some, but not all of these AHO features are encountered also in patients affected by PPHP, who typically show no laboratory abnormalities. Autosomal dominant PHP type Ib (AD-PHP1B) is caused by heterozygous maternal deletions within GNAS or STX16, which are associated with loss-of-methylation (LOM) at exon A/B alone or at all maternally methylated GNAS exons. LOM at exon A/B and the resulting biallelic expression of A/B transcripts reduces Gsα expression, thus leading to hormonal resistance. Epigenetic changes at all differentially methylated GNAS regions are also observed in sporadic PHP1B, the most frequent disease variant, which remains unresolved at the molecular level, except for rare cases with paternal uniparental isodisomy or heterodisomy of chromosome 20q (patUPD20q).
Similar content being viewed by others
References
Albright F et al (1942) Pseudohypoparathyroidism—an example of “Seabright-Bantam syndrome”. Endocrinology 30:922–932
Tashjian AH Jr, Frantz AG, Lee JB (1966) Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci USA 56:1138–1142
Albright F, Forbes AP, Henneman PH (1952) Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians 65:337–350
Chase LR, Melson GL, Aurbach GD (1969) Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest 48(10):1832–1844
Levine MA et al (1980) Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 94:1319–1324
Farfel Z et al (1980) Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N Engl J Med 303:237–242
Levine MA et al (1986) Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright’s hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 62:497–502
Levine MA et al (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556
Blatt C et al (1988) Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human. Proc Natl Acad Sci USA 85(20):7642–7646
Kozasa T et al (1988) Isolation and characterization of the human Gsα gene. Proc Natl Acad Sci USA 85:2081–2085
Weinstein LS et al (1990) Mutations of the Gs α-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 87:8287–8290
Patten JL et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322:1412–1419
Turan S et al (2015) Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS. Bone 71:53–57
Davies AJ, Hughes HE (1993) Imprinting in Albright’s hereditary osteodystrophy. J Med Genet 30:101–103
Wilson LC et al (1994) Parental origin of Gsα gene mutations in Albright’s hereditary osteodystrophy. J Med Genet 31:835–839
Levine MA (2002) Pseudohypoparathyroidism. In: Raisz LG, Bilezikian JP, Rodan GA (eds) Principles of bone biology. Academic Press, New York, pp 1137–1159
Thiele S et al (2011) Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsalpha-receptor interaction. Hum Mutat 32(6):653–660
Linglart A et al (2002) GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab 87(1):189–197
Kaplan FS, Shore EM (2000) Progressive osseous heteroplasia. J Bone Miner Res 15(11):2084–2094
Winter JSD, Hughes IA (1980) Familial pseudohypoparathyroidism without somatic anomalities. Can Med Assoc J 123:26–31
Weinstein L et al (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675–705
Schipani E, Kruse K, Jüppner H (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268(5207):98–100
Bettoun JD et al (1997) Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 82:1031–1040
Suarez F et al (1995) Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism. J Clin Endocrinol Metab 80:965–970
Fukumoto S et al (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 81:2554–2558
Jüppner H et al (1998) The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 95(20):11798–11803
Liu J et al (2000) A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 106:1167–1174
Bastepe M et al (2001) Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 10(12):1231–1241
Ablow RC, Hsia YE, Brandt IK (1977) Acrodysostosis coinciding with pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. Am J Roentgenol 128(1):95–99
Graham JM Jr et al (2001) Radiographic findings and Gs-alpha bioactivity studies and mutation screening in acrodysostosis indicate a different etiology from pseudohypoparathyroidism. Pediatr Radiol 31(1):2–9
Wilson LC et al (1997) Normal erythrocyte membrane Gs alpha bioactivity in two unrelated patients with acrodysostosis. J Med Genet 34(2):133–136
Linglart A et al (2011) Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 364(23):2218–2226
Michot C et al (2012) Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am J Hum Genet 90(4):740–745
Elli FM et al (2016) The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network. J Clin Endocrinol Metab 101:3657–3668
Blomstrand S, Claësson I, Säve-Söderbergh J (1985) A case of lethal congenital dwarfism with accelerated skeletal maturation. Pediatr Radiol 15:141–143
Jobert AS et al (1998) Absence of functional receptors parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34–40
Klopocki E et al (2010) Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 86(3):434–439
Thomas-Teinturier C et al (2016) Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review. Am J Med Genet A 170(3):734–742
Thiele S et al (2016) From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the European EuroPHP network. Eur J Endocrinol 175:1–17
Peters J et al (1994) Mapping studies of the distal imprinting region of mouse chromosome 2. Genet Res 63(3):169–174
Gejman PV et al (1991) Genetic mapping of the Gs-α subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics 9:782–783
Rao VV, Schnittger S, Hansmann I (1991) G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics 10(1):257–261
Levine MA, Modi WS, O’Brien SJ (1991) Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2 → q13.3 in human by in situ hybridization. Genomics 11(2):478–479
Liu J et al (2000) Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 20(16):5808–5817
Germain-Lee EL et al (2002) Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 296(1):67–72
Hayward B et al (2001) Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107:R31–R36
Mantovani G et al (2002) The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87(10):4736–4740
Ischia R et al (1997) Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 272:11657–11662
Hayward B et al (1998) The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 95:10038–10043
Peters J et al (1999) A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA 96:3830–3835
Klemke M et al (2000) Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J Biol Chem 275:33633–33640
Bastepe M et al (2002) Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit. Mol Endocrinol 16(8):1912–1919
Lovisetti-Scamihorn P et al (1999) Relative amounts and molecular forms of NESP55 in various bovine tissues. Brain Res 829(1–2):99–106
Li T et al (2000) Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus. Genomics 69(3):295–304
Ishikawa Y et al (1990) Alternative promoter and 5′ exon generate a novel Gsα mRNA. J Biol Chem 265:8458–8462
Swaroop A et al (1991) Differential expression of novel Gs alpha signal transduction protein cDNA species. Nucleic Acids Res 19(17):4725–4729
Liu J et al (2000) Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 20:5808–5817
Puzhko S et al (2011) Parathyroid hormone signaling via Galphas is selectively inhibited by an NH(2)-terminally truncated Galphas: implications for pseudohypoparathyroidism. J Bone Miner Res 26(10):2473–2485
Hayward B, Bonthron D (2000) An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 9:835–841
Wroe SF et al (2000) An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci USA 97(7):3342–3346
Coombes C et al (2003) Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus. Mol Cell Biol 23(16):5475–5488
Long DN et al (2007) Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab 92(3):1073–1079
Mouallem M et al (2008) Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf) 68(2):233–239
Turan S et al (2014) Postnatal establishment of allelic Galphas silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Galphas disruption. J Bone Miner Res 29(3):749–760
Marx SJ, Hershman JM, Aurbach GD (1971) Thyroid dysfunction in pseudohypoparathyroidism. J Clin Endocrinol Metab 33(5):822–828
Mantovani G et al (2003) Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 88(9):4070–4074
Vigone MC, Di Frenna M, Weber G (2015) Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update. J Endocrinol Invest 38(8):835–840
Levine MA, Jap TS, Hung W (1985) Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia. J Pediatr 107(6):919–922
Faull CM et al (1991) Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med 78(287):251–264
Moses AM et al (1986) Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism. J Clin Endocrinol Metab 62(1):221–224
Kaplan FS, Hahn GV, Zasloff MA (1994) Heterotopic ossification: two rare forms and what they can teach us. J Am Acad Orthop Surg 2(5):288–296
Shore E et al (2002) Paternally-inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 346:99–106
Ahmed SF, Barr DG, Bonthron DT (2002) GNAS1 mutations and progressive osseous heteroplasia. N Engl J Med 346(21):1669–1671
Eddy MC et al (2000) Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. J Bone Miner Res 15(11):2074–2083
Adegbite NS et al (2008) Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A 146A(14):1788–1796
Yu S et al (1995) A deletion hot-spot in exon 7 of the Gs alpha gene (GNAS1) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 4(10):2001–2002
Lemos MC, Thakker RV (2015) GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders. Hum Mutat 36(1):11–19
Elli FM et al (2013) Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations. Hum Mutat 34(3):411–416
Richard N et al (2013) Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLalphas in fetal development. J Clin Endocrinol Metab 98(9):E1549–E1556
Liu J, Erlichman B, Weinstein L (2003) The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 88:4336–4341
de Nanclares GP et al (2007) Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright’s hereditary osteodystrophy. J Clin Endocrinol Metab 92(6):2370–2373
Mariot V et al (2008) A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab 93(3):661–665
Unluturk U et al (2008) Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright’s hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci 336(1):84–90
Mantovani G et al (2010) Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 95(2):651–658
Takatani R et al (2016) Analysis of multiple families with single individuals affected by pseudohypoparathyroidism type Ib (PHP1B) reveals only one novel maternally inherited GNAS deletion. J Bone Miner Res 31:796–805
Sharma A, Phillips AJ, Jüppner H (2015) Hypoplastic metatarsals—beyond cosmesis. N Engl J Med 373(22):2189–2190
Zazo C et al (2011) Gsα activity is reduced in erythrocyte membranes of patients with pseudohypoparathyroidism due to epigenetic alterations at the GNAS locus. J Bone Miner Res 26:1864–1870
Turan S, Bastepe M (2013) The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene. Horm Res Paediatr 80(4):229–241
de Jan de Beur S et al (2003) Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 73:314–322
Maupetit-Mehouas S et al (2011) Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. J Med Genet 48(1):55–63
Rochtus A et al (2016) Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects. Clin Epigenetics 8:10
Bastepe M, Lane AH, Jüppner H (2001) Paternal uniparental isodisomy of chromosome 20q—and the resulting changes in GNAS1 methylation—as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 68(5):1283–1289
Bastepe M et al (2011) Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone 48(3):659–662
Fernández-Rebollo E et al (2011) New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol 163(6):953–962
Dixit A et al (2013) Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q. J Clin Endocrinol Metab 98(1):E103–E108
Takatani R et al (2015) Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B). Bone 79:15–20
Bastepe M et al (2003) Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 112(8):1255–1263
Linglart A et al (2005) A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 76(5):804–814
Elli FM et al (2014) Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR. J Clin Endocrinol Metab 99(4):E724–E728
Richard N et al (2012) A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 97(5):E863–E867
Bastepe M et al (2005) Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37(1):25–27
Chillambhi S et al (2010) Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J Clin Endocrinol Metab 95(8):3993–4002
Linglart A, Bastepe M, Jüppner H (2007) Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol (Oxf) 67(6):822–831
Bréhin AC et al (2015) Loss of methylation at GNAS exon A/B is associated with increased intrauterine growth. J Clin Endocrinol Metab 100(4):E623–E631
Richard N et al (2013) Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLalphas in fetal development. J Clin Endocrinol Metab 98(9):E1549–E1556
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
For this review article no studies with human participants or animal experimentation were performed by the two authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Tafaj, O., Jüppner, H. Pseudohypoparathyroidism: one gene, several syndromes. J Endocrinol Invest 40, 347–356 (2017). https://doi.org/10.1007/s40618-016-0588-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-016-0588-4